Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2010
09/16/2010CA2754688A1 Novel isoindolin-1-one derivative
09/16/2010CA2754681A1 Benzofuranyl derivatives used as glucokinase inhibitors
09/16/2010CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010CA2754562A1 Rosuvastatin and atorvastatin derivatives
09/16/2010CA2753498A1 Plasma-adapted balanced electrolyte solution
09/16/2010CA2751901A1 Mineralocorticoid receptor antagonist and methods of use
09/15/2010EP2228389A2 Antibodies against vascular endothelial growth factor 2
09/15/2010EP2228378A1 Monosebacate of pyrazole derivative
09/15/2010EP2228069A1 Antagonists of protein kinase c-epsilon (pkcepsilon) and their use for the treatment of aberrant glucose metabolism associated therewith.
09/15/2010EP2228066A1 Pharmaceutical compositions of sulphonylurea-based active pharmaceutical ingredient with excellent dissolution properties
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP2228060A1 Oral dosage forms comprising fenofibrate
09/15/2010EP2227456A2 Hedgehog pathway antagonists and therapeutic applications thereof
09/15/2010EP2227452A2 Pyridine compounds
09/15/2010EP2227244A1 Cgrp as a therapeutic agent
09/15/2010EP2227243A2 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
09/15/2010EP2027132B1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
09/15/2010EP1968561B1 Treatment of diabetic nephropathy
09/15/2010EP1758596B9 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
09/15/2010EP1611144B1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists
09/15/2010EP1536837B1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
09/15/2010EP1501819B1 Estrogen receptor modulators
09/15/2010EP1303596B1 Morpholino antisense oligomers as enzyme inhibitors for improving pharmacokinetics of a drug
09/15/2010EP1250055B1 Immune modulation with death receptor-induced apoptosis
09/15/2010CN1969918B Oral fat emulsion
09/15/2010CN1931261B Blood pressure and blood lipid lowering capsule and its preparation process
09/15/2010CN101835763A Oxadiazolidinedione compound
09/15/2010CN101835737A Spiro-ring compound and use thereof for medical purposes
09/15/2010CN101835480A Ligand agent for peroxisome proliferator-activated receptor (PPAR)
09/15/2010CN101835478A Laxative agent
09/15/2010CN101831372A Method for brewing wine by using pumpkin
09/15/2010CN101831369A Golden fungus gingko yellow wine, preparation method and efficacy thereof
09/15/2010CN101830969A Balsam pear hypoglycemic MC-JJ0104 polypeptide analogue by microwave-accelerated solid-phase synthesis and application thereof
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/15/2010CN101830876A C-aryl glucoside derivative, preparation method thereof and application thereof in medicine
09/15/2010CN101829319A Pharmaceutical compositions and methods for insulin treatment
09/15/2010CN101829316A Lactalbumin hydrolysate and application thereof in preparing glucose-lowering medicament
09/15/2010CN101829290A Medicament for treating diabetic peripheral neuropathy and preparation method thereof
09/15/2010CN101829275A Traditional Chinese medicine for treating diabetes mellitus
09/15/2010CN101829272A Traditional Chinese medicine composition for treating diabetes mellitus and preparation method thereof
09/15/2010CN101829271A Chinese medicinal compound with function of treating diabetes and preparation method and application thereof
09/15/2010CN101829269A Compound raidx astragali and chickpea granules and preparation method thereof
09/15/2010CN101829258A Chinese medicinal composition preparation for strengthening spleen and stomach, enriching blood and promoting secretion of body fluid and quality control method
09/15/2010CN101829238A Traditional Chinese medicine powder for treating hypertension and hyperlipidemia
09/15/2010CN101829237A Medicament for treating hyperlipermia caused by phlegm-turbidity and blood stasis syndrome and preparation process thereof
09/15/2010CN101829228A Method for extracting digitonin
09/15/2010CN101829211A Fish compound traditional Chinese medicinal preparation and preparation method thereof
09/15/2010CN101829205A Quality control method of abnormal savda munziq granules
09/15/2010CN101829204A Preparation method of abnormal savda munziq granules and application thereof
09/15/2010CN101829199A Application of ranunculus japonicus extract in preparing anti-tumor and anti-tumor angiogenesis drugs
09/15/2010CN101829196A Preparation method of high-content buckwheat total flavone
09/15/2010CN101829194A Composition for curing II-type diabetes mellitus and preparation method thereof
09/15/2010CN101829192A Artocarpus nitidus extract and use thereof
09/15/2010CN101829181A Extract of the effective-part of Gynostemma pentaphyllum and preparation method thereof
09/15/2010CN101829180A Gynostemma pentaphyllum soft capsule preparation and preparation method thereof
09/15/2010CN101829166A Big fruit sea-buckthorn pomace flavonoid and preparation method thereof
09/15/2010CN101829160A Functional composition with functions of controlling blood sugar and enhancing nutrition
09/15/2010CN101829159A Method for preparing selenium-enriched monkey head mushroom capsule
09/15/2010CN101829158A Pig blood composition and pig blood chewable tablet made therefrom
09/15/2010CN101829151A Preparation method of fly micromolecular active substance with blood fat-reducing function
09/15/2010CN101829142A Application of sodium bicarbonate in regulating blood fat and reducing blood sugar
09/15/2010CN101829108A Application of diterpene ginkgolide
09/15/2010CN101829079A Application of compound of (E)-5-[6-hydroxy-5-(3-methyl-1-butenyl)-2-benzofuranyl] phenyl-1, 3-diol to preparation of pancrelipase inhibitor
09/15/2010CN101829069A Pitavastatin calcium double-layer osmotic pump controlled-release tablet and preparation method thereof
09/15/2010CN101829050A Natural brain protein hydrolysate injection and preparation method thereof
09/15/2010CN101828771A Calcium carbide liquid health-care clothes
09/15/2010CN101828715A Health-care food for patient with hyperlipidemia, hypertension and hypercholesterolemia
09/15/2010CN101828712A Process for preparing ginsenoside acid degraded product and application of ginsenoside acid degraded product
09/15/2010CN101828700A Tea drink capable of reducing blood fat and blood pressure
09/15/2010CN101828660A Health-care food for hyperglycemia patient
09/15/2010CN101601647B Riboflavine sodium phosphate composition injection and preparation method thereof
09/15/2010CN101253903B Health food with fat-reducing function and its preparation
09/15/2010CN101233884B Method for preparing bead type gynostemma pentaphylla health-care tea
09/15/2010CN101229373B Medicine compounds for treating diabetic nephropathy
09/15/2010CN101214269B Method for extracting and concentrating total flavones of ilex hainanensis
09/15/2010CN101112359B Method for preparing transparent water-dispersible concentrated liquor of beta-carotin
09/15/2010CN101069742B Pancreatic kininogenase tablet and preparing method
09/15/2010CN101019848B Application of ferricitras in preparation of medicine to prevent and treat angiosteosis
09/15/2010CN101006091B Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
09/14/2010US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest
09/14/2010US7795450 aministering N-(2,4-di-n-amylpentanoic acid amide)-tryptophanamide, for the treatment of diseases associated with the decreased binding of magnesium to the plasma membranes of their cells, such as hypertension, diabetes, non-insulin depepndent diabetes, pre-eclampsia and eclampsia
09/14/2010US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
09/14/2010US7795302 use of topical formulation for treating rosacea containing a combination of an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14
09/14/2010US7795301 preventing myxoviruses infection using 3-(acetylamino)-2-{3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-1-[1,2-dihydroxyethyl]-19,20-dihydroxy-3,16-dioxo-2,17-dioxa-4,15-diazaicos-1-yl}-4-{[amino(imino)methyl]-amino}-3,4-dihydro-2H--pyran-6-carboxylic acid; viricides
09/14/2010US7795269 3-Ethyl-1-propyl-8-{1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl}-1,3,7-trihydropurine-2,6-dione; antiasthmatic and antidiarrhea agents
09/14/2010US7795267 G protein-coupled receptor antagonists such as phenyl tetrahydro-3-oxo-1,1-diphenyl-3H-oxazolo[3,4-a]pyrazine-7(1H)-carboxylate, used for treating cancer, Alzheimer's disease, dementia, eating disorder, hypertension, glandular disorders, diabetes and hyperlipemia
09/14/2010US7795229 beta-lactam compounds having a C-glycoside in the molecule, in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor selected from atorvastatin and rosuvastatin; synergistic
09/14/2010US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases
09/14/2010US7795204 supplementing the diet of an athlete with substances which increase the concentration of nitric oxide (NO) or increase its half life in the body, in combination with a source of amino acids, may provide surprising enhancement of an athlete's muscle
09/14/2010US7794995 use of several sequential steps, including subcellular fractionation to isolate a plasma membrane fraction and the use of gel filtration or chromatography that separates molecules according to their size or affinity; drug screening
09/14/2010US7794745 Mixture of glucans and sterols
09/14/2010US7794744 Nutritional modules
09/14/2010CA2401757C Novel fatty acid analogues
09/14/2010CA2373266C Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
09/14/2010CA2295140C Stable insulin formulations
09/14/2010CA2262014C Adipogenic differentiation of human mesenchymal stem cells
09/14/2010CA2260291C Antagonists of intestinotrophic glp-2 peptides
09/14/2010CA2222217C Use of fibroblast growth factors mutants to stimulate bone growth
09/10/2010WO2010102171A2 Secreted ap2 and methods of inhibiting same
09/10/2010WO2010101949A1 8-substituted quinolines and related analogs as sirtuin modulators
1 ... 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 ... 1298